FRANCISCO
MARTÍN MOLINA
CONTRATO MARÍA ZAMBRANO SENIOR
Hospital Universitario Reina Sofia
Córdoba, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario Reina Sofia (9)
2024
2023
-
Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells
Molecular Therapy - Nucleic Acids, Vol. 32, pp. 322-339
2022
-
Efficacy and safety of universal (TCRKO) ARI-0001 CAR-T cells for the treatment of B-cell lymphoma
Frontiers in Immunology, Vol. 13
-
Physiological lentiviral vectors for the generation of improved CAR-T cells
Molecular Therapy - Oncolytics, Vol. 25, pp. 335-349
2021
-
Improved functionality of integration-deficient lentiviral vectors (IDLVs) by the inclusion of IS2 protein docks
Pharmaceutics, Vol. 13, Núm. 8
2020
-
Exosome: A new player in translational nanomedicine
Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-27
-
Genome-edited adult stem cells: Next-generation advanced therapy medicinal products
Stem Cells Translational Medicine, Vol. 9, Núm. 6, pp. 674-685
-
Using Gene Editing Approaches to Fine-Tune the Immune System
Frontiers in Immunology, Vol. 11
2016
-
NUMB inactivation confers resistance to imatinib in chronic myeloid leukemia cells
Cancer Letters, Vol. 375, Núm. 1, pp. 92-99